Phase Ib and Phase II Studies of Anti-PD-1 Antibody MK-3475 in Combination With Bevacizumab for the Treatment of Metastatic Renal Cell Carcinoma: Big Ten Cancer Research Consortium GU14-003

Status: Completed

Learn more:

• clinicaltrials.gov: #NCT02348008
• See Study Information on Big Ten CRC Website